ViewRay Inc Stock
ViewRay Inc Stock
For the coming years our community has positive and negative things to say abot the ViewRay Inc stock. Criterium "EBIT Margin" gathered the most positive votes but regarding "EBIT Margin" there were negative voices in the community.
Pros and Cons of ViewRay Inc in the next few years
Pros
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of ViewRay Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| ViewRay Inc | - | - | - | - | - | - | - |
| MicroVision Inc | 1.590% | 5.311% | -3.557% | -17.376% | -40.954% | -87.022% | 81.854% |
| Fonar Corp. New | -0.670% | -7.500% | -20.000% | 4.225% | -16.384% | 3.497% | -16.128% |
| Fluidigm Corp. | 1.770% | 6.481% | -4.167% | 74.242% | 11.650% | -44.188% | - |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-15
From a high-level perspective, it appears that ViewRay (VRAY), a company in the Healthcare Equipment & Supplies industry, has been facing financial challenges over the years. A closer examination of the company's financial statements reveals some concerning trends, which will be discussed in detail below. However, it's worth mentioning that this industry has significant growth potential, and it must be taken into consideration in the analysis.
*Pros: *
Revenue Growth: ViewRay has experienced a growth in its total revenue year-over-year. From 2020 to 2022, the revenue increased from $57,017,000 to $102,206,000, which is a positive indication of the company's demand in the market.
Comments
ViewRay, Inc. (NASDAQ: VRAY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for VRAY provided by MarketBeat
ViewRay, Inc. (NASDAQ: VRAY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for VRAY provided by MarketBeat
ViewRay, Inc. (NASDAQ: VRAY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for VRAY provided by MarketBeat